ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 271 filers reported holding ACCELERON PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,752,000 | -94.6% | 21,796 | -96.1% | 0.00% | -95.5% |
| Q2 2021 | $69,559,000 | -7.4% | 554,274 | +0.1% | 0.02% | -12.0% |
| Q1 2021 | $75,089,000 | +5.6% | 553,708 | -0.4% | 0.02% | 0.0% |
| Q4 2020 | $71,119,000 | -23.6% | 555,882 | -32.8% | 0.02% | -34.2% |
| Q3 2020 | $93,052,000 | +149.6% | 826,914 | +111.3% | 0.04% | +137.5% |
| Q2 2020 | $37,285,000 | +269.8% | 391,375 | +248.8% | 0.02% | +220.0% |
| Q1 2020 | $10,083,000 | +906.3% | 112,219 | +387.8% | 0.01% | +400.0% |
| Q4 2018 | $1,002,000 | -24.0% | 23,004 | -0.0% | 0.00% | – |
| Q3 2018 | $1,318,000 | +5.6% | 23,014 | -31.2% | 0.00% | -100.0% |
| Q3 2017 | $1,248,000 | +37.4% | 33,430 | +43.4% | 0.00% | 0.0% |
| Q4 2014 | $908,000 | – | 23,317 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |